Long‐term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A <scp>STELLAR</scp> interim analysis-Reference-Cited by-同舟云学术

Long‐term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis

Published:2024-08-06 Issue:10 Volume:99 Page:2037-2040
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Arnold Staci D.¹^ORCID,Bakshi Nitya¹,Ross Diana¹,Smith Crystal¹,Sinha Cynthia¹,Veludhandi Anirudh¹^ORCID,Dutreuil Valerie²,Bai Shasha²,Meacham Lillian R.¹,Guilcher Greg³,Bhatia Monica⁴,Abraham Allistair⁵⁶,Kasow Kimberly A.⁷,Haight Ann¹,El Rassi Fuad⁸,Stenger Elizabeth¹,Lipscomb Joseph⁹,Krishnamurti Lakshmanan¹⁰

Affiliation:

1. Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta Emory University Atlanta Georgia USA

2. Pediatric Biostatistics Core, Department of Pediatrics Emory School of Medicine Atlanta Georgia USA

3. Alberta Children's Hospital Calgary Alberta Canada

4. Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation Columbia University Medical Center New York New York USA

5. Children's National Hospital Washington DC USA

6. Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute National Institutes of Health Bethesda Maryland USA

7. Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill North Carolina USA

8. Georgia Comprehensive Sickle Cell Center at Grady Health System Emory University School of Medicine Atlanta Georgia USA

9. Emory University Rollins School of Public Health Atlanta Georgia USA

10. Section of Pediatric Hematology/Oncology/BMT Yale School of Medicine New Haven Connecticut USA

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27436

Reference6 articles.

1. How I treat sickle cell disease with hematopoietic cell transplantation

2. Health Status and Healthcare Use in a National Sample of Children with Sickle Cell Disease

3. A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy

4. Adherence to hydroxyurea, health-related quality of life domains, and patients’ perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults

5. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report